VM Femara 2.5mg

Femara – Letrozol 2.5mg is a non-steroidal aromatase inhibitor that works by blocking the aromatase enzyme, responsible for converting androgens into estrogen. In clinical medicine, Femara is used in postmenopausal women with hormone-sensitive breast cancer. In performance enhancement contexts, it is used to manage or prevent estrogenic side effects such as water retention, gynecomastia, and fat gain, particularly during or after anabolic steroid cycles.